Dr. Siddhartha Mukherjee
speaker
438 appearances
1 recordings
1 series
first heard Jul 2026
last heard 23 Jul
Dr. Siddhartha Mukherjee’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
And those are people who will pick up people with so-called BRCA1, BRCA1, BRCA2 mutations, among other things.
Number two is that there is actually a genetic test.
If you have a family history of breast cancer or of any of these cancers, there's a genetic test that even if you are not BRCA1 or BRCA2 positive, it will give you a score of the risk that you have, genetic risk for breast cancer.
It's a score.
It's called a polygenic risk score.
Again, it's not perfect, but if women who do have a polygenic risk score, I'm...
If they do have one, certainly if they have BRCA1, BRCA2, and some of these other breast cancer genes, I'm recommending them to enroll in a trial with intensive screening.
There are many around.
Some of them use a combination of MRI and mammograms sort of alternatively.
Some of them are MRI only.
What I'm really hoping for is that there's a test that will come along
which won't be as invasive and which will not have as many false positives as a mammogram that we can use that as a potential way to screen these younger women.
Okay.
So it means the cancer has spread beyond, certainly spread beyond the original local site.
It's gone through the bowel wall.
And in many cases, depending on what kind of cancer, has started invading the lymph nodes.
So it's called advanced cancer in the case of colorectal cancer.
Now, astonishingly, I mean, I'm so sorry that you had to go through all of this, and the world is very sorry for it, I think.
Astonishingly, immunological therapy still works in stage three in some cases.
I'm sorry it didn't work in this particular case, but it really works.
Showing 241–260 of 438 · page 13 of 22
← Previous
Next →